Posts

Terremoto Raises $108M to Make an 'Earthquake' in Small Molecule Space

on
Terremoto raised $108M in Series C funding 1 2 The funding will support clinical trial development of drugs targeting AKT 2 The company is focusing on small molecule drug development 1 The funding round has been reported as recent news across multiple biotech publications 1 2 Sources: 1. https://www.nie-podam.pl/wiadomosci/112258103 2. https://www.brutalist.bio

NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments

on

Pivotal Pancreatic Cancer Data Fuels Revolution Medicines' Upsized $2B Offering

on

Beeline Biotech Launches with $300M Funding and Bristol Myers Squibb-Derived Pipeline

on

Magnetic Seizure Therapy Shows Efficacy and Safety Comparable to Electroconvulsive Therapy for Depression

on

Mike Sciandra's Journey from Gambling Addiction to Recovery and Advocacy

on

2026 AAPS National Biotechnology Conference: Plenary Speakers and Key Details Announced

on

Revolution Medicines Secures $2B Funding from Royalty Pharma for RAS Cancer Drugs as Biotech Sector Heats Up

on

Bristol Myers Squibb and Bain Capital Launch New Autoimmune Disease Biotech Company

on

Biogen's $5.6B Apellis Acquisition: Key Biotech Deals Including Telix's $600M Raise and Obsidian's IPO Plans

on

Spotlight On: Tackling Core Challenges in Drug R&D with AI

on

Johnson & Johnson Reports Strong Q1 Results and Raises 2026 Guidance

on

FDA Requests Additional Safety Data from Eli Lilly on Foundayo for Liver and Heart Risks

on